Premium
This is an archive article published on September 11, 2020

Centre tells states: Do RT-PCR to catch false negatives after rapid antigen test

Symptomatic negative cases are those where the patient has symptoms of Covid, but tests negative. Since rapid antigen tests are known to have high degre of false negatives, the ICMR had mandated that symptomatic negative cases must get a retest through RT-PCR.

Reiterating that all symptomatic negative cases of rapid antigen tests (RAT) must mandatorily take an RT-PCR retest for Covid, the Centre on Thursday directed all states to set up two teams each, at the level of the district and the state, to monitor and ensure that no potentially positive case is missed out.

Symptomatic negative cases are those where the patient has symptoms of Covid, but tests negative. Since rapid antigen tests are known to have high degre of false negatives, the ICMR had mandated that symptomatic negative cases must get a retest through RT-PCR.

Explained| How the coronavirus (COVID-19) test works

Government sources, part of the team monitoring the pandemic, said the decision came after they found that a “few big states” are now reporting a significantly high percentage of symptomatic negatives not being retested through RT-PCR, thereby spreading the infection among the general population.

“When we did data analytics, which is done on daily and weekly, we found in a few states only 30-35 per cent of symptomatic negatives were undergoing RT-PCR test. Which means, roughly 70 per cent of symptomatic negatives were still spreading the infection,” source said.

Sources said while trends differ across states, nationally, of the total tests, 65 per cent are RT-PCR and the remaining RAT. However, sources underlined that there is no correlation between states conducting high number of RATs and those reporting a higher percentage of asymptomatic negatives not being retested through RT-PCR tests.

For instance, sources pointed out, Bihar, which is currently conducting 80 per cent RATs and 20 per cent RT-PCR tests, was not found to be reporting a higher percentage of symptomatic negatives not being retested through RT-PCR. “Proportion of rapid antigen to RT-PCR has nothing to do with retesting. Retesting is the question of the state’s efficiency or incompetence. Our focus is only to retest the symptomatic negatives,” sources said.

Also in Explained| How India tests for Covid-19 

To track this closely, states have been directed to set up a monitoring mechanism in every district. “Although this has happened in very few states, we have written to all the states saying they should have a designated individual at the district level or a district-level team which should be doing daily monitoring of the symptomatic negatives in the district. Similarly, they should have a team at the state level, which should collect this data and conduct a review on a daily basis. They should analyse what is the universe to be subjected to RT-PCR retest, and then they must be covered immediately so that their potential to spread the infection is curbed,” a source said.

Story continues below this ad

In its advisory to states, the Centre has reiterated ICMR’s guidelines that two specific categories of persons must get a retest through RT-PCR: all symptomatic negative cases of RAT; and asymptomatic negative cases of RAT that develop symptoms within 2 to 3 days of being tested negative.

ICMR guidelines mandate compulsory retesting of symptomatic negatives in the backdrop of RAT’s sensitivity ranging from 50 per cent to 85 per cent, depending on the viral load of the patient. So, to rule out false negatives, where the patient may spread the infection, the ICMR has mandated that if any person develops symptoms days after he tests negative after RAT, that persons should get an RT-PCR test.

As City Editor ( Delhi) at the Indian Express, Kaunain Sheriff  leads city reporting with a sharp focus on accountability journalism, data-driven stories, and ground-level impact. As the National Health Editor he leads the newsroom’s in-depth coverage of pressing health issues. He is the author of Johnson & Johnson Files: The Indian Secrets of a Global Giant, a definitive investigation into the accountability of one of the world’s most powerful pharmaceutical corporations. Areas of Expertise Investigative Reporting: Has deep expertise in investigative reporting spanning public health, regulatory affairs, drug safety, and the criminal justice system. His work sits at the intersection of governance, law, and accountability, with a particular focus on how regulatory failures, institutional lapses, and policy decisions affect citizens’ rights and safety. Data Journalism: Has extensively on big data–driven investigations, including analyses of flagship government schemes and large datasets on criminal trials, uncovering systemic gaps. Global Collaborations Kaunain is a key contributor to major international journalistic projects: The Implant Files: Collaborated with the International Consortium of Investigative Journalists (ICIJ) to expose global malpractices in the medical device industry. Chinese Big-Data Investigation: Uncovered how a foreign data firm monitored thousands of prominent Indian institutions and individuals in real-time. Awards & Recognition His commitment to "Journalism of Courage" has been recognized with the industry's highest honors: Ramnath Goenka Award for Excellence in Journalism SOPA Award (Society of Publishers in Asia) Red Ink Award (Mumbai Press Club) Indian Express Excellence Awards (Triple recipient for investigations into the NSA abuse in UP, Vyapam scam, and the anti-Sikh riots). Education: Studied Mechanical Engineering at Visvesvaraya Technological University (VTU), Bangalore, before moving to Delhi to pursue his passion for journalism. His engineering training informs his analytical approach, enabling him to decode technical, legal, and data-heavy systems with precision. Social media LinkedIn:  linkedin.com/in/kaunain-sheriff-3a00ab99 X ( fromerly Twitter): @kaunain_s ... Read More

Stay updated with the latest - Click here to follow us on Instagram

Advertisement
Loading Recommendations...
Latest Comment
Post Comment
Read Comments